3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
2
Rhabdoid Tumor
1
Papillary renal cell carcinoma, sporadic
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Melanoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hereditary leiomyomatosis and renal cell cancer
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
29
fludarabine
19
fludarabine phosphate
13
Methotrexate
12
blinatumomab
11
Whole-Body Irradiation
11
Vincristine
8
Tacrolimus
8
Mycophenolic Acid
8
Cytarabine
8
Dexamethasone
7
Cyclosporine
7
Busulfan
7
merphos
6
Thiotepa
6
Specimen Handling
6
Mercaptopurine
6
Melphalan
6
Granulocyte Colony-Stimulating Factor
6
pegaspargase
5
Peripheral Blood Stem Cell Transplantation
5
Mesna
5
Filgrastim
5
venetoclax
4
prednylidene
4
Stem Cell Transplantation
4
Sirolimus
4
Prednisone
4
Leukapheresis
4
Immunotherapy, Adoptive
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Erlotinib Hydrochloride
×
30 days
×
Clear all
No trials found.